CRVS Cash & Equivalents
Corvus Pharmaceuticals Inc · Cash & Equivalents
CRVS Cash & Equivalents
Latest reported$4.58Mperiod ending
CRVS FY Cash & Equivalents ($12.52M → $4.58M)
Annual Cash & Equivalents
High-resolution chart · PNG
CRVS cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 4,576,000 | |
| 8,740,000 | |
| 12,620,000 | |
| 13,159,000 | |
| 63,458,000 | |
| 16,455,000 | |
| 5,154,000 | |
| 114,597,000 | |
| 90,055,000 | |
| 134,896,000 | |
| 4,105,000 | |
| 12,517,000 |